Multicentric Randomized Study of Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.
Phase of Trial: Phase III
Latest Information Update: 25 Apr 2016
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Deep vein thrombosis; Thrombosis
- Focus Therapeutic Use
- Acronyms RIPORT
- 21 Apr 2016 Status changed from recruiting to suspended.
- 24 Sep 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 23 Sep 2015 New trial record